Can late gadolinium enhancement by cardiovascular magnetic resonance identify coronary artery disease as the etiology of new onset congestive heart failure?

[1]  R. F. Hoyt,et al.  Cardiac magnetic resonance imaging , 2004, Postgraduate Medical Journal.

[2]  R. Senior,et al.  Myocardial Contrast Echocardiography for Distinguishing Ischemic From Nonischemic First-Onset Acute Heart Failure: Insights Into the Mechanism of Acute Heart Failure , 2005, Circulation.

[3]  J. Schulz-Menger,et al.  Diagnostic performance of cardiovascular magnetic resonance in patients with suspected acute myocarditis: comparison of different approaches. , 2005, Journal of the American College of Cardiology.

[4]  C. Kramer,et al.  Cardiovascular magnetic resonance: Structure, function, perfusion, and viability , 2005, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[5]  F. Ridocci,et al.  Noninvasive diagnosis of coronary artery disease in patients with heart failure and systolic dysfunction of uncertain etiology, using late gadolinium-enhanced cardiovascular magnetic resonance. , 2005, Journal of the American College of Cardiology.

[6]  S. Rahimtoola,et al.  Myocardial Hibernation-a delicate balance , 2004 .

[7]  M. Sivananthan,et al.  Role of MRI in clinical cardiology , 2004, The Lancet.

[8]  C. Roongsritong,et al.  Common causes of troponin elevations in the absence of acute myocardial infarction: incidence and clinical significance. , 2004, Chest.

[9]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.

[10]  N. Samani,et al.  Magnetic resonance perfusion imaging in patients with coronary artery disease: a qualitative approach , 2002, The International Journal of Cardiovascular Imaging.

[11]  C H Lorenz,et al.  Differentiation of Heart Failure Related to Dilated Cardiomyopathy and Coronary Artery Disease Using Gadolinium‐Enhanced Cardiovascular Magnetic Resonance , 2003, Circulation.

[12]  Valentin Fuster,et al.  Cardiac magnetic resonance imaging: a “one-stop-shop” evaluation of myocardial dysfunction , 2002, Current opinion in cardiology.

[13]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[14]  M. Cerqueira,et al.  Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart. A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. , 2002, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[15]  B. Schnackenburg,et al.  Assessment of Myocardial Viability With Contrast-Enhanced Magnetic Resonance Imaging: Comparison With Positron Emission Tomography , 2002, Circulation.

[16]  V. Fuster,et al.  Treatment of congestive heart failure: guidelines for the primary care physician and the heart failure specialist. , 2001, Archives of internal medicine.

[17]  Edwin Wu,et al.  Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction , 2001, The Lancet.

[18]  O. Simonetti,et al.  The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. , 2000, The New England journal of medicine.

[19]  G. Thiene,et al.  Positron emission tomography is a useful tool in differentiating idiopathic from ischemic dilated cardiomyopathy. , 2000, International journal of cardiology.

[20]  Jeroen J. Bax,et al.  Improvement of left ventricular ejection fraction, heart failure symptoms and prognosis after revascularization in patients with chronic coronary artery disease and viable myocardium detected by dobutamine stress echocardiography. , 1999, Journal of the American College of Cardiology.

[21]  J. Murray,et al.  ACC/AHA guidelines for coronary angiography. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions. , 1999, Journal of the American College of Cardiology.

[22]  R. Bonow,et al.  Chronic heart failure in the United States: a manifestation of coronary artery disease. , 1998, Circulation.

[23]  V. Gil.  [Hibernating myocardium. An incomplete adaptation to ischemia]. , 1998, Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology.

[24]  G. Beller,et al.  Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. , 1997, Circulation.

[25]  G. Perna,et al.  Regional wall motion analysis by dobutamine stess echocardiography to distinguish between ischemic and nonischemic dilated cardiomyopathy. , 1996, American heart journal.

[26]  M. Phelps,et al.  Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. , 1995, Circulation.

[27]  N. Fineberg,et al.  Dobutamine stress echocardiography: detection of coronary artery disease in patients with dilated cardiomyopathy. , 1994, Journal of the American College of Cardiology.

[28]  S. Kaul,et al.  Quantitative Planar Rest‐Redistribution 201 Imaging in Detection of Myocardial Viability and Prediction of Improvement in Left Ventricular Function After Coronary Bypass Surgery in Patients With Severely Depressed Left Ventricular Function , 1993, Circulation.

[29]  J. Corbett,et al.  Utility of various radionuclide techniques for distinguishing ischemic from nonischemic dilated cardiomyopathy. , 1992, Archives of internal medicine.

[30]  M. Phelps,et al.  Differentiating cardiomyopathy of coronary artery disease from nonischemic dilated cardiomyopathy utilizing positron emission tomography. , 1991, Journal of the American College of Cardiology.

[31]  J. Parrillo,et al.  Dynamic limitation of coronary vasodilator reserve in patients with dilated cardiomyopathy and chest pain. , 1987, Journal of the American College of Cardiology.

[32]  G. E. Newman,et al.  The effects of coronary revascularization on left ventricular function in ischemic heart disease. , 1985, The Journal of thoracic and cardiovascular surgery.

[33]  R. Henkin,et al.  Segmental wall motion abnormalities in dilated cardiomyopathy: a common finding and good prognostic sign. , 1984, Journal of the American College of Cardiology.

[34]  C. Maynard,et al.  Results of coronary artery surgery in patients with poor left ventricular function (CASS). , 1983, Circulation.

[35]  C. Fisch,et al.  ABNORMAL Q WAVES SIMULATING MYOCARDIAL INFARCTION IN DIFFUSE MYOCARDIAL DISEASES. , 1964, American heart journal.